President Biden has pledged $500 million and up to one million doses of mpox vaccines to support Central and Eastern Africa ...

Centivo has raised $75 million in equity and debt financing to expand its affordable healthcare plans for self-funded ...

Bluebird bio has announced a restructuring to cut costs by 20% and achieve quarterly cash flow break-even by late 2025. The ...

Swiss contract development and manufacturing organization (CDMO) Lonza (VTX: LONN) has signed a long-term commercial supply ...

People affected Niemann-Pick disease, a rare and fatal genetic disorder, have waited a lifetime for an effective medicine.

USA and Japan based privately held company Aurion Biotech has announced the commercial launch of Vyznova (neltependocel) in ...

Wave Life Sciences has announced positive interim data from the ongoing Phase II FORWARD-53 study of WVE-N531, which is an ...

Biomedicines (Generate) today announced a multi-target collaboration with Swiss pharm giant Novartis to discover and develop ...

The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved Otsuka’s Lupkynis (voclosporin) for lupus nephritis ...

Japanese drugmaker Eisai closed down 2.3% at 5,587 yen today, despite news of regulatory approvals for two of its drugs.

Research and Manufacturers of America (PhRMA) has taken its legal challenge against the US government’s drug pricing reforms ...

BioAtla has granted Context Therapeutics an exclusive global license for BA3362, a T cell-engaging antibody targeting solid ...